These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 25031415)

  • 41. Incisional Injury Modulates Morphine Reward and Morphine-Primed Reinstatement: A Role of Kappa Opioid Receptor Activation.
    Nwaneshiudu CA; Shi XY; Clark JD
    Anesth Analg; 2020 Jan; 130(1):248-257. PubMed ID: 31166231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of a new derivate of kisspeptin-10 - Kissorphin (KSO) on the rewarding effects of morphine in the conditioned place preference (CPP) test in male rats.
    Gibula-Tarlowska E; Kedzierska E; Piechura K; Silberring J; Kotlinska JH
    Behav Brain Res; 2019 Oct; 372():112043. PubMed ID: 31226311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Strain differences in the rewarding and dopamine-releasing effects of morphine in rats.
    Shoaib M; Spanagel R; Stohr T; Shippenberg TS
    Psychopharmacology (Berl); 1995 Jan; 117(2):240-7. PubMed ID: 7753973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. dCA1-NAc shell glutamatergic projection mediates context-induced memory recall of morphine.
    Liu YY; Liu L; Zhu L; Yang X; Tong K; You Y; Yang L; Gao Y; Li X; Chen DS; Hao JR; Sun N; Gao C
    Pharmacol Res; 2021 Oct; 172():105857. PubMed ID: 34461223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gentiopicroside attenuates morphine rewarding effect through downregulation of GluN2B receptors in nucleus accumbens.
    Liu SB; Ma L; Guo HJ; Feng B; Guo YY; Li XQ; Sun WJ; Zheng LH; Zhao MG
    CNS Neurosci Ther; 2012 Aug; 18(8):652-8. PubMed ID: 22621711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mesoaccumbens dopamine signaling alteration underlies behavioral transition from tolerance to sensitization to morphine rewarding properties during morphine withdrawal.
    Sun L; Hu L; Li Y; Cui C
    Brain Struct Funct; 2014 Sep; 219(5):1755-71. PubMed ID: 23775491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opioid modulation of social play reward in juvenile rats.
    Achterberg EJM; van Swieten MMH; Houwing DJ; Trezza V; Vanderschuren LJMJ
    Neuropharmacology; 2019 Nov; 159():107332. PubMed ID: 30218673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blockade of dopamine D1 receptors in male rats disrupts morphine reward in pain naïve but not in chronic pain states.
    Grenier P; Mailhiot MC; Cahill CM; Olmstead MC
    J Neurosci Res; 2022 Jan; 100(1):297-308. PubMed ID: 31721270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydrocodone and morphine possess similar rewarding effects and reduce ERK and CREB phosphorylation in the nucleus accumbens.
    Tenayuca JM; Nazarian A
    Synapse; 2012 Oct; 66(10):918-22. PubMed ID: 22715022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased entrances to side compartments indicate incubation of craving in morphine-induced rat and tree shrew CPP models.
    Sun Y; Pan Z; Ma Y
    Pharmacol Biochem Behav; 2017 Aug; 159():62-68. PubMed ID: 28720521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potentiation of morphine-induced antinociception by harmaline: involvement of μ-opioid and ventral tegmental area NMDA receptors.
    Alijanpour S; Zarrindast MR
    Psychopharmacology (Berl); 2020 Feb; 237(2):557-570. PubMed ID: 31740992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapses.
    Bie B; Zhu W; Pan ZZ
    J Pharmacol Exp Ther; 2009 Apr; 329(1):290-6. PubMed ID: 19168708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats.
    Piepponen TP; Kivastik T; Katajamäki J; Zharkovsky A; Ahtee L
    Pharmacol Biochem Behav; 1997 Sep; 58(1):275-9. PubMed ID: 9264103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conditioned Place Preference (CPP) in Rats: From Conditioning to Reinstatement Test.
    Scherma M; Fattore L; Fratta W; Fadda P
    Methods Mol Biol; 2021; 2201():221-229. PubMed ID: 32975803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic administration of N-acetylcysteine during the extinction period and on the reinstatement day decreased the maintenance of morphine rewarding properties in the rats.
    Katebi SN; Torkaman-Boutorabi A; Vousooghi N; Riahi E; Haghparast A
    Behav Brain Res; 2021 Sep; 413():113451. PubMed ID: 34256079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective modulation of tonic aversive qualities of neuropathic pain by morphine in the central nucleus of the amygdala requires endogenous opioid signaling in the anterior cingulate cortex.
    Navratilova E; Nation K; Remeniuk B; Neugebauer V; Bannister K; Dickenson AH; Porreca F
    Pain; 2020 Mar; 161(3):609-618. PubMed ID: 31725062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappa-opioid receptor agonist U69593.
    Shippenberg TS; LeFevour A; Thompson AC
    Eur J Pharmacol; 1998 Mar; 345(1):27-34. PubMed ID: 9593590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ghrelin receptor antagonism of morphine-induced conditioned place preference and behavioral and accumbens dopaminergic sensitization in rats.
    Jerabek P; Havlickova T; Puskina N; Charalambous C; Lapka M; Kacer P; Sustkova-Fiserova M
    Neurochem Int; 2017 Nov; 110():101-113. PubMed ID: 28958601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Behavioral and neurochemical analysis of ongoing bone cancer pain in rats.
    Remeniuk B; Sukhtankar D; Okun A; Navratilova E; Xie JY; King T; Porreca F
    Pain; 2015 Oct; 156(10):1864-1873. PubMed ID: 25955964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repeated administration of dopaminergic agents in the nucleus accumbens and morphine-induced place preference.
    Zarrindast MR; Azami BN; Rostami P; Rezayof A
    Behav Brain Res; 2006 May; 169(2):248-55. PubMed ID: 16472879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.